Artery Research

<Previous Article In Issue
Download article (PDF)
Next Article In Issue>
Volume 24, Issue C, December 2018, Pages 77 - 77

4.6 INFLAMMATION AND AORTIC STIFFNESS. A MULTICENTRE LONGITUDINAL STUDY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Authors
Luca Zanoli1, Kadir Ozturk2, Maria Cappello3
1Nephrology, Department of Clinical and Experimental Medicine, Policlinico Universitario, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy
2Department of Gastroenterology, Gulhane School of Medicine, Etlik, Ankara, Turkey
3DIBIMIS, School of Medicine, University of Palermo, Italy
Available Online 4 December 2018.
DOI
10.1016/j.artres.2018.10.045How to use a DOI?
Abstract

Background: Inflammatory Bowel Disease (IBD) is characterized by a low prevalence of traditional risk factors, an increased aortic pulse-wave velocity (aPWV) [1] and an excess of cardiovascular events. We have previously hypothesized that the difference between expected and observed cardiovascular risk could be explained by chronic inflammation [2]. In this multicentre longitudinal study, we tested the hypothesis that increased aPWV is reversible with anti-tumor necrosis factor-alpha (anti-TNFα) therapy.

Methods: We enrolled 334 patients (82 patients with ulcerative colitis [UC], 85 patients with Crohn’s disease [CD] and 167 healthy control subjects matched for age, sex and mean blood pressure) from 3 Centres in Europe and followed up them for 4 years (range 2.5–5.7 years).

Results: At baseline, IBD patients had higher aPWV than controls. IBD patients in remission and those treated with anti-TNFα during follow-up experienced an aortic destiffening whereas aPWV increased in those with active disease and those treated with salicylates (Figure 1, P = 0.01). Disease duration (P = 0.02) and, in UC patients, the increase in CRP during follow-up (P = 0.02) were associated with aortic stiffening. All these results were confirmed after adjustment for major confounders. Finally, the duration of anti-TNFα therapy was not associated with the magnitude of the reduction in aPWV at the end of follow-up (P = 0.85). This finding could suggest that anti-TNFα therapy has a beneficial effect on functional arterial stiffening.

Conclusions: Long-term anti-TNFα therapy reduced aPWV, an established surrogate measure of cardiovascular risk, in patients with IBD. This suggests that effective control of inflammation may reduce cardiovascular risk in these patients.

Open Access
This is an open access article distributed under the CC BY-NC license.

References

1.L Zanoli, P Boutouyrie, P Fatuzzo, et al., Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease, J Am Heart Assoc., Vol. 6, No. 10, 2017.
2.L Zanoli, S Rastelli, G Inserra, and P Castellino, Arterial structure and function in inflammatory bowel disease, World J Gastroenterol, Vol. 21, No. 40, 2015, pp. 11304-11.
<Previous Article In Issue
Download article (PDF)
Next Article In Issue>
Journal
Artery Research
Volume-Issue
24 - C
Pages
77 - 77
Publication Date
2018/12/04
ISSN (Online)
1876-4401
ISSN (Print)
1872-9312
DOI
10.1016/j.artres.2018.10.045How to use a DOI?
Open Access
This is an open access article distributed under the CC BY-NC license.

Cite this article

risenwbib
TY  - JOUR
AU  - Luca Zanoli
AU  - Kadir Ozturk
AU  - Maria Cappello
PY  - 2018
DA  - 2018/12/04
TI  - 4.6 INFLAMMATION AND AORTIC STIFFNESS. A MULTICENTRE LONGITUDINAL STUDY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
JO  - Artery Research
SP  - 77
EP  - 77
VL  - 24
IS  - C
SN  - 1876-4401
UR  - https://doi.org/10.1016/j.artres.2018.10.045
DO  - 10.1016/j.artres.2018.10.045
ID  - Zanoli2018
ER  -